poisar

Stocks · News reference

Labcorp Announces Availability of Roche's Ventana Pten RxDx Assay, First Immunohistochemistry Companion Diagnostic Test Approved By FDA To Determine Pten Protein Loss In Prostate Adenocarcinoma Patients

Aug 4, 2026, 11:13 AMBenzinga Newsdesk

The assay helps identify patients who may be eligible for treatment with AstraZeneca's TRUQAP® (capivasertib) in combination with abiraterone acetate and prednisone.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

LH
Source
benzinga
Observed
Aug 4, 2026, 11:13 AM
Checked
Aug 4, 2026, 11:13 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 27, 2026, 5:00 PMDelveinsight

    Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsight

    The global blood-based biomarkers market is projected to grow from USD 8.5 billion in 2025 to USD 18.5 billion by 2034, driven by increasing demand for non-invasive diagnostics, rising chronic disease prevalence, and advances in genomics and liquid biopsy technologies. North America leads with 44% market share, while Asia-Pacific shows fastest growth. Key players include Roche, Abbott, Siemens Healthineers, and Thermo Fisher Scientific.

    Read original at globenewswire-inc
    RHHBYABTTMODGXLH
  2. Aug 27, 2026, 10:52 AMResearchandmarkets.Com

    Animal Testing and Non-Animal Alternative Testing Market Outlook 2025-2035 - Featuring Profiles of Charles River Laboratories, Labcorp, and Eurofins Scientific

    The global animal testing and non-animal alternative testing market reached $15.19 billion in 2025 and is projected to grow to $23.01 billion by 2035 at a CAGR of 4-4.5%. While animal testing dominated with 80.1% market share in 2025, non-animal alternative testing is expected to grow faster at 6.3% CAGR through 2030, driven by advances in organ-on-chip, organoids, AI biosimulation, and genomics. The pharmaceutical industry led end-user applications with 50.1% market share, while North America was the largest regional market at 38.6% of global revenue.

    Read original at globenewswire-inc
    CRLLHERRFY
  3. Aug 26, 2026, 4:39 AMNot Specified

    Testie Health Launches Nationwide to Make STI Testing Simpler, Faster, and Less Stigmatized

    Testie Health, a consumer health company founded by Thea Rose, has launched nationwide with a direct-to-lab STI testing model that allows customers to purchase testing panels online and visit nearby laboratories for sample collection without scheduling a doctor's appointment. The service aims to destigmatize routine STI testing and make it a normal part of preventive healthcare, with results delivered within 48 hours and licensed provider support available for positive results.

    Read original at globenewswire-inc
    LH